artesunate-sulfadoxine-pyrimethamine
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antimalarial drug combination
|
| gptkbp:ATCCode |
P01BD05
|
| gptkbp:contains |
gptkb:sulfadoxine
gptkb:artesunate pyrimethamine |
| gptkbp:contraindication |
severe liver disease
sulfa allergy |
| https://www.w3.org/2000/01/rdf-schema#label |
artesunate-sulfadoxine-pyrimethamine
|
| gptkbp:mechanismOfAction |
inhibits parasite folate synthesis and heme detoxification
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting allergic reactions |
| gptkbp:usedFor |
treatment of malaria
|
| gptkbp:usedIn |
gptkb:Africa
gptkb:Asia |
| gptkbp:WHOModelListOfEssentialMedicines |
yes
|
| gptkbp:bfsParent |
gptkb:artemisinin_combination_therapy
|
| gptkbp:bfsLayer |
6
|